Please complete the CAPTCHA to continue
@mybinxhealth.com
✓
2 phones found area 617 and 978
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Jack Crowley, Cpa, Mba is listed as FINANCE AND OPERATIONS LEADER at binx health, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at mybinxhealth.com, phone signal with area code 617, 978, and a matched LinkedIn profile for Jack Crowley, Cpa, Mba.
Jack Crowley, Cpa, Mba previously worked as Chief Financial Officer at Binx Health and Chief Financial Officer at Ora, Inc.. Jack Crowley, Cpa, Mba holds Mba from Umass Boston.
This section adds company-level context without repeating Jack Crowley, Cpa, Mba's masked contact details.
AeroLeads found 1 current-domain work email signal for Jack Crowley, Cpa, Mba. Compare company email patterns before reaching out.
FINANCE AND OPERATIONS LEADERTransformational Chief Financial Officer with demonstrated results in successful initial and secondary public offerings, capital structure enhancements, analyst collaboration, and investor relations. Deep industry expertise in life sciences and professional services public accounting. Collaborative leader who effectively partners with senior executive team and Board of Directors. Results-driven finance executive with a demonstrated track record with Fortune 500 and Private Equity backed companies. Accomplishments-driven career highlighted by rapid promotions to increasingly responsible positions. Proven expertise in driving continuous improvement, proactive solutions, and sustainable best in class processes and operational results. Reputation for recruiting and developing high performing teams and providing visionary and highly engaged leadership to shape organizational evolution to achieve strategic corporate objectives. • IPO Leadership – Led finance team through successful IPO process raising $175 million as Chief Accounting Officer and subsequent follow on equity offering raising an additional $50 million as Chief Financial Officer.• Operational Efficiency – Key successes include the divesture of multiple underperforming businesses and contracting into long term supply agreements that were more accretive for the company, undertaking a nuclear medicine products contracting strategy to support predictable revenue and planned production levels, as well as the in-sourcing of manufacturing capabilities that will provide for gross margin improvement.• Executive Leadership – Led significant organizational activities as executive sponsor of ERP implementation and a 3-year Corporate Efficiencies Program which delivered over $6 million in annual run rate savings, and Project Patriot, a $30 million build out of in-house manufacturing line. Executive relationship liaison with sole contract manufacturer for flagship product.
Listed skills include Forecasting, Auditing, Managerial Finance, Accounting, and 17 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Boston, Massachusetts, Us
Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer. Binx is developing a suite of offerings that service healthcare needs where people live, work and shop.
Andover, Massachusetts, Us
Ora is a leading full-service preclinical and clinical ophthalmic drug and device development firm.Over 40 years of global experience has given us unparalleled insight into clinical strategy and regulatory requirements, all tailored to meet your study specific needs.
Salinas, California, Us
Personal Genome Diagnostics (PGDx) empowers the fight against cancer by unlocking actionable information from the genome. PGDx was established by researchers from Johns Hopkins University who are pioneers in cancer genome sequencing and liquid biopsy technologies.
Bedford, Massachusetts, Us
A $400M global life sciences company engaged in the development, manufacture, and commercialization of medical imaging products.Responsible for all Finance/Treasury, Information Technology, and Investor Relationship activities. Led organization of 60 + individuals.• Led transformational recapitalization efforts since IPO in June 2015, whereby the company has paid down over $135 million in debt, improving its leverage ratio from 5.0x to 2.1x. In addition, initiated significant refinancing and repricing of debt, reducing interest rate by 140 basis points and generating annual savings of approximately $4 million debt service costs. Further enhanced access to liquidity by replacing an asset backed loan with a revolving credit facility.• Established credibility in the marketplace with both analysts and investors as a new Public Company, focused on transparency and consistent delivery on commitments to Wall Street. • Managed divestiture of evolving shareholder base as private equity owner divested remaining shareholder holdings through end of 2017. Results manifested in the growth of the company’s market capitalization, going from approximately $102.6 million in December 2015 to approximately $772.3 million in December 2017.• Led the divesture of multiple underperforming businesses and entered into long term supply agreements that were more accretive for the company. Initiated a nuclear medicine products contracting strategy to support predictable revenue and planned production levels, as well as the in-sourcing of manufacturing capabilities that supported gross margin improvement.
Bedford, Massachusetts, Us
Vice President, Finance (2013–2014)Global Corporate Controller, Assistant Treasurer (2011-2013)Reported to the CFO. Responsible for all corporate controllership activities, including corporate close and internal reporting process, external reporting process with Securities and Exchange Commission, external audit relationship, payroll, accounts payable, corporate tax, and Sarbanes Oxley compliance. Finance representative on capital committee, disclosure committee and ethics and compliance committee. Significant participation in partnering with all business unit finance heads, investor relations and all forecasting and budgeting processes. Managed a staff of 18.• Developed staff to enable high achieving individuals to rotate positions while maintaining rigorous close and reporting process.• Implemented technologies and processes to improve efficiencies and reduce headcount for finance department.• Enhanced functionality and quality of tax department, including implementation of compliance software solution.
Reported to Chief Accounting Officer. Responsible for corporate close and internal reporting process, external reporting process with Securities and Exchange Commission, external audit relationships and Sarbanes Oxley compliance. Responsible for establishing centralized external reporting function and implementing relevant processes and procedures.• Led initial registration of debt with Securities and Exchange Commission.• Implemented multiple initiatives to improve quality and timeliness of SEC reporting process.• Reduced closing cycle time by 100% by implementing “best-in-class” cross-functional processes.• Improved quality of close as measured by reduction in errors and time required by development of proactive consolidation solutions and issue identification and resolution.• Established robust sub-certification process to ensure quality of deliverable.• Implemented technologies and processes to improve efficiencies and reduce headcount for financial management reporting.• Managed multiple vendor relationships including outside auditor Deloitte.
Cambridge, Ma, Us
A $4B Fortune 500 life sciences company engaged in the development, manufacture, and commercialization of oncology, neurology, and immunology therapies.Responsible for all corporate activities, including corporate close process, budgeting, forecasting, partnering with all business unit finance heads, managing external audit relationships, participating in investor relations presentations, preparing filings with the Securities and Exchange Commission, and complying with Sarbanes Oxley procedures. Managed staff of 12.• Reduced closing cycle time by 25% by implementing “best-in-class” cross-functional processes.• Improved quality of close as measured by reduction in errors and time required by development of proactive consolidation solutions and issue identification and resolution.• Developed staff to enable high achieving individuals to rotate positions while maintaining rigorous close process.• Managed business unit finance accounting issues identification and issue resolution, including global expansion matters.
Cambridge, Ma, Us
Responsible for establishing centralized external reporting function and implementing relevant processes and procedures.• Improved filing time of 10K by 25 days by developing enterprise wide processes and procedures.• Consistently filed 10K and 10Q on same day of earnings release, representing best in class process and procedures.• Implemented technologies and processes to improve efficiencies and adjust headcount for financial reporting.
Waltham, Ma, Us
A $5B Fortune 500 life science company engaged in manufacturing products and services for scientific research and clinical markets worldwide.Managed all SEC filings, treasury accounting, Sarbanes Oxley and statutory audit compliance, external audit coordination and all compliance with generally accepted accounting principles for over 100 individual businesses.• Improved 10K and 10Q quality and filing cycle times to consistently file on same day as earnings release.• Developed corporate standardized purchase accounting template to support multiple global acquisitions.
Gb
A $25B global accounting firm with offices in over 150 countries.- Lead Senior Manager, Life Science Practice and Entrepreneurial Center (2004-2005)- Manager/Senior Manager, Technology, Information, Communication, Entertainment Business Practice (1998-2004)• Coordinated Northeast life science practice while continuing to serve as an audit manager for selected life science clients.• Managed relationships with venture capitalists and investment bankers, provided resource allocation, client target identification and service and proposal development.• Drove entrepreneurial center initiatives, supported early stage life science companies by sponsoring educational events and presenting on industry and accounting trends and developments.• Managed key client relationships, including CFO and Board level communications.• Delivered audit and review services, assistance with initial public offering and other registration statements.
Quick answers generated from the profile data available on this page.
Jack Crowley, Cpa, Mba works for binx health.
Jack Crowley, Cpa, Mba is listed as FINANCE AND OPERATIONS LEADER at binx health.
AeroLeads has found 1 work email signal at @mybinxhealth.com for Jack Crowley, Cpa, Mba at binx health.
AeroLeads has found 2 phone signal(s) with area code 617, 978 for Jack Crowley, Cpa, Mba at binx health.
Jack Crowley, Cpa, Mba is based in Cambridge, Massachusetts, United States while working with binx health.
Jack Crowley, Cpa, Mba has worked for Binx Health, Ora, Inc., Personal Genome Diagnostics, Lantheus Medical Imaging, and Lantheous Medical Imaging.
You can use AeroLeads to view verified contact signals for Jack Crowley, Cpa, Mba at binx health, including work email, phone, and LinkedIn data when available.
Jack Crowley, Cpa, Mba holds Mba from Umass Boston.
Jack Crowley, Cpa, Mba is listed with skills including Forecasting, Auditing, Managerial Finance, Accounting, Finance, Sec Filings, Gaap, and Cross Functional Team Leadership.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts